Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itaru Hashimoto

Showing results (41-50 of 128) with videos related to

Pageof 13
Sort By:
In Vivo (Athens, Greece)|October 30, 2024
Breakfast Protein Intake of One-third of Daily Requirement Can Maintain Lean Body Mass Post-distal GastrectomyShinsuke Nagasawa, Hiroki Akiyama, Mie Tanabe, et al.
Cancer Diagnosis & Prognosis|May 5, 2025
Analysis of Early Progression in Advanced Renal Cell Carcinoma Treated With Nivolumab Plus IpilimumabSosuke Yamamoto, Toru Aoyama, Yukio Maezawa, et al.
Oncology Letters|May 13, 2024
A propensity‑matched analysis of the prognostic value of advanced lung cancer inflammation index in patients with gastric cancer after curative resectionItaru Hashimoto, Mie Tanabe, Shizune Onuma, et al.
In Vivo (Athens, Greece)|February 26, 2025
The Hemoglobin, Albumin, Lymphocyte and Platelet (HALP) Score as an Independent Prognostic Factor for Esophageal Cancer Patients who Received Curative TreatmentSosuke Yamamoto, Toru Aoyama, Yukio Maezawa, et al.
Anticancer Research|December 30, 2023
Asialoglycoprotein Receptor 2 Expression in Patients With Locally Advanced Gastric Cancer After Curative ResectionTakashi Oshima, Itaru Hashimoto, Yukihiko Hiroshima, et al.
Anticancer Research|December 30, 2023
Clinical Significance of Chitinase-3-like Protein 1 Gene Expression in Patients With Locally Advanced Gastric CancerTakashi Oshima, Itaru Hashimoto, Yukihiko Hiroshima, et al.
In Vivo (Athens, Greece)|February 28, 2024
Clinical Impact of the C-reactive Protein-albumin-lymphocyte Index in Post-gastrectomy Patients With Gastric CancerItaru Hashimoto, Mie Tanabe, Shizune Onuma, et al.
Anticancer Research|April 27, 2024
The Prognostic Immune and Nutritional Indices Are Independent Prognostic Factors for Esophageal Cancer Patients Who Receive Curative TreatmentToru Aoyama, Itaru Hashimoto, Yukio Maezawa, et al.
Annals of Surgical Oncology|May 25, 2026
Association Between Quantitative Blood Flow Measurement Using SPY-QP Software and Prevention of Anastomotic Leakage in Esophageal Cancer SurgeryHayato Watanabe, Sho Sato, Hiroki Kondo, et al.
Anticancer Research|December 30, 2023
Clinical Significance of Pregnancy Zone Protein Expression in Patients With Locally Advanced Gastric Cancer After Curative ResectionTakashi Oshima, Itaru Hashimoto, Yukihiko Hiroshima, et al.
Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
In Vivo (Athens, Greece)|October 30, 2024
Breakfast Protein Intake of One-third of Daily Requirement Can Maintain Lean Body Mass Post-distal GastrectomyShinsuke Nagasawa, Hiroki Akiyama, Mie Tanabe, et al.
Cancer Diagnosis & Prognosis|May 5, 2025
Analysis of Early Progression in Advanced Renal Cell Carcinoma Treated With Nivolumab Plus IpilimumabSosuke Yamamoto, Toru Aoyama, Yukio Maezawa, et al.
Oncology Letters|May 13, 2024
A propensity‑matched analysis of the prognostic value of advanced lung cancer inflammation index in patients with gastric cancer after curative resectionItaru Hashimoto, Mie Tanabe, Shizune Onuma, et al.
In Vivo (Athens, Greece)|February 26, 2025
The Hemoglobin, Albumin, Lymphocyte and Platelet (HALP) Score as an Independent Prognostic Factor for Esophageal Cancer Patients who Received Curative TreatmentSosuke Yamamoto, Toru Aoyama, Yukio Maezawa, et al.
Anticancer Research|December 30, 2023
Asialoglycoprotein Receptor 2 Expression in Patients With Locally Advanced Gastric Cancer After Curative ResectionTakashi Oshima, Itaru Hashimoto, Yukihiko Hiroshima, et al.
Anticancer Research|December 30, 2023
Clinical Significance of Chitinase-3-like Protein 1 Gene Expression in Patients With Locally Advanced Gastric CancerTakashi Oshima, Itaru Hashimoto, Yukihiko Hiroshima, et al.
In Vivo (Athens, Greece)|February 28, 2024
Clinical Impact of the C-reactive Protein-albumin-lymphocyte Index in Post-gastrectomy Patients With Gastric CancerItaru Hashimoto, Mie Tanabe, Shizune Onuma, et al.
Anticancer Research|April 27, 2024
The Prognostic Immune and Nutritional Indices Are Independent Prognostic Factors for Esophageal Cancer Patients Who Receive Curative TreatmentToru Aoyama, Itaru Hashimoto, Yukio Maezawa, et al.
Annals of Surgical Oncology|May 25, 2026
Association Between Quantitative Blood Flow Measurement Using SPY-QP Software and Prevention of Anastomotic Leakage in Esophageal Cancer SurgeryHayato Watanabe, Sho Sato, Hiroki Kondo, et al.
Anticancer Research|December 30, 2023
Clinical Significance of Pregnancy Zone Protein Expression in Patients With Locally Advanced Gastric Cancer After Curative ResectionTakashi Oshima, Itaru Hashimoto, Yukihiko Hiroshima, et al.
Pageof 13